Department of Surgery, Hepatopancreatobiliary Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
HPB (Oxford). 2021 Jan;23(1):118-126. doi: 10.1016/j.hpb.2020.05.005. Epub 2020 Jun 24.
A subset of patients have no risk factors for the development of hepatocellular carcinoma (HCC). We evaluated differences in clinical variables between patients with and without risk factors who underwent surgical resection.
A prospectively maintained database was queried for patients who underwent R0/R1 resection of HCC between 1992 and 2016. Risk factors included HCV, HBV, hemochromatosis, alcoholic liver disease, or cirrhosis, stage 2 or 3 fibrosis or severe (>66%) steatosis of the non-neoplastic liver. Variables were compared between patients with and without risk factors.
There were 416 patients who underwent resection; 276 (66%) had known risk factors while 140 (34%) did not. Patients without risk factors were more likely to be older, female and have hyperlipidemia or coronary artery disease (p < 0.004). These patients had larger tumors and were more likely to undergo major hepatectomy (p < 0.001). There was no difference in OS (5-year, 56% vs 47%, p = 0.335), RFS (27% vs 24%, p = 0.398), or the rates of intrahepatic (HR:1.16 [95%CI:0.95-1.57], p = 0.344) and extrahepatic recurrences (HR:0.72 [95%CI:0.4-1.3], p = 0.261) between groups.
Patients without risk factors for HCC presented with larger tumors yet had similar outcomes, suggesting these tumors may represent a different disease process, and underlying liver dysfunction can influence overall outcome.
一部分患者没有发生肝细胞癌(HCC)的危险因素。我们评估了行根治性切除术的患者中有无危险因素者的临床变量差异。
检索 1992 年至 2016 年间行 HCC 根治性切除术患者的前瞻性数据库。危险因素包括 HCV、HBV、血色病、酒精性肝病或肝硬化、2 或 3 期纤维化或非肿瘤性肝脏重度(>66%)脂肪变性。比较有危险因素和无危险因素患者的变量。
共有 416 例患者行切除术;276 例(66%)有已知危险因素,140 例(34%)无危险因素。无危险因素的患者年龄更大,女性更多,血脂异常或冠心病更常见(p<0.004)。这些患者的肿瘤更大,更有可能接受大范围肝切除术(p<0.001)。OS(5 年,56%vs47%,p=0.335)、RFS(27%vs24%,p=0.398)和肝内(HR:1.16[95%CI:0.95-1.57],p=0.344)及肝外复发率(HR:0.72[95%CI:0.4-1.3],p=0.261)无差异。
无 HCC 危险因素的患者表现为更大的肿瘤,但结局相似,提示这些肿瘤可能代表不同的疾病过程,基础肝功能障碍可能影响整体结局。